Your browser is no longer supported. Please, upgrade your browser.
WVE Wave Life Sciences Ltd. monthly Stock Chart
WVE [NASD]
Wave Life Sciences Ltd.
Index- P/E- EPS (ttm)-5.72 Insider Own1.30% Shs Outstand37.76M Perf Week-19.92%
Market Cap305.10M Forward P/E- EPS next Y-2.54 Insider Trans-10.41% Shs Float28.25M Perf Month-7.02%
Income-193.60M PEG- EPS next Q-1.20 Inst Own87.70% Short Float22.19% Perf Quarter1.25%
Sales16.00M P/S19.07 EPS this Y-12.90% Inst Trans-4.02% Short Ratio8.81 Perf Half Y-54.66%
Book/sh1.86 P/B4.34 EPS next Y32.30% ROA-53.50% Target Price16.71 Perf Year-80.21%
Cash/sh3.90 P/C2.07 EPS next 5Y- ROE-144.60% 52W Range6.61 - 43.00 Perf YTD0.81%
Dividend- P/FCF- EPS past 5Y- ROI-327.00% 52W High-81.21% Beta-0.15
Dividend %- Quick Ratio1.60 Sales past 5Y- Gross Margin- 52W Low22.24% ATR1.50
Employees301 Current Ratio1.60 Sales Q/Q-33.30% Oper. Margin- RSI (14)43.81 Volatility11.83% 19.39%
OptionableYes Debt/Eq0.00 EPS Q/Q-28.70% Profit Margin- Rel Volume0.55 Prev Close9.00
ShortableYes LT Debt/Eq0.00 EarningsMar 02 BMO Payout- Avg Volume711.14K Price8.08
Recom2.10 SMA20-16.75% SMA50-6.47% SMA200-57.60% Volume392,363 Change-10.22%
Dec-31-19Downgrade SVB Leerink Outperform → Mkt Perform $33 → $10
Nov-01-19Initiated Guggenheim Buy $43
Jul-15-19Initiated Cowen Market Perform
Apr-17-19Reiterated H.C. Wainwright Buy $49 → $33
Aug-07-18Initiated Stifel Buy $56
Jul-23-18Initiated H.C. Wainwright Buy $49
Mar-19-18Reiterated Mizuho Buy $34 → $65
Feb-15-17Initiated H.C. Wainwright Buy $41
Nov-10-16Resumed Leerink Partners Outperform
Dec-07-15Initiated Sun Trust Rbsn Humphrey Buy $26
Dec-07-15Initiated Leerink Partners Outperform $20
Dec-07-15Initiated JMP Securities Mkt Outperform $52
Dec-07-15Initiated Jefferies Buy $28
Mar-24-20 10:38AM  Edited Transcript of WVE earnings conference call or presentation 2-Mar-20 1:00pm GMT Thomson Reuters StreetEvents
Mar-02-20 07:55AM  Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates Zacks -6.04%
06:45AM  Wave Life Sciences Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update GlobeNewswire
Feb-26-20 11:55AM  Is Wave Life Sciences Ltd.'s (NASDAQ:WVE) CEO Being Overpaid? Simply Wall St.
Feb-24-20 12:30PM  Analysts Estimate Wave Life Sciences (WVE) to Report a Decline in Earnings: What to Look Out for Zacks -7.42%
Feb-19-20 08:00AM  Wave Life Sciences to Present at the Cowen and Company 40th Annual Healthcare Conference GlobeNewswire
Feb-18-20 08:00AM  Wave Life Sciences to Present Preclinical In Vivo and In Vitro Data for SNP3-Targeting Huntingtons Disease Program at CHDI Foundations 15th Annual HD Therapeutics Conference GlobeNewswire
Feb-13-20 08:05AM  Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 GlobeNewswire
Jan-22-20 11:48AM  New FDA documents shed light on agency's rejection of Sarepta drug American City Business Journals
Jan-16-20 09:39AM  Wave Life Sciences Enters Oversold Territory Zacks
Jan-14-20 09:55AM  Wave Life Sciences Enters Oversold Territory Zacks
Dec-31-19 06:10AM  Experts question Cambridge biotech's strategy after trial failure American City Business Journals
Dec-30-19 04:10PM  Why This Biotech Stock Had Two Devastating Crashes This Month Investor's Business Daily -49.46%
07:00AM  Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b/2a PRECISION-HD2 Trial in Huntingtons Disease GlobeNewswire
06:24AM  Wave Life Sciences Shares Off by Half After Disappointing Trial for Huntington Disease TheStreet.com
Dec-24-19 12:18PM  Here's Why We're Watching Wave Life Sciences's (NASDAQ:WVE) Cash Burn Situation Simply Wall St.
Dec-23-19 09:52AM  Options Traders Expect Huge Moves in Wave Life Sciences (WVE) Stock Zacks
Dec-16-19 04:09PM  Why This Biotech's 55% Plunge Will Ultimately Benefit Its Biggest Rival Investor's Business Daily -55.35%
02:37PM  Wave Life Sciences Stock Folds on Drug Decision Schaeffer's Investment Research
09:27AM  Cambridge biotech's stock price tumbles on Duchenne drug failure American City Business Journals
07:00AM  Wave Life Sciences Announces Discontinuation of Suvodirsen Development for Duchenne Muscular Dystrophy GlobeNewswire
Dec-11-19 02:21PM  Did Hedge Funds Drop The Ball On WAVE Life Sciences Ltd. (WVE) ? Insider Monkey
Dec-06-19 02:23PM  Hedge Funds Love Liberty Tripadvisor (LTRPA) Way More Than These 3 Stocks Insider Monkey
Nov-14-19 10:02AM  Implied Volatility Surging for Wave Life Sciences (WVE) Stock Options Zacks
Nov-06-19 12:15PM  If You Had Bought Wave Life Sciences (NASDAQ:WVE) Stock A Year Ago, You'd Be Sitting On A 40% Loss, Today Simply Wall St.
Nov-05-19 07:15PM  Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:05PM  Wave Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Nov-01-19 10:30AM  Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-28-19 02:13PM  Is WAVE Life Sciences Ltd. (WVE) Going To Burn These Hedge Funds ? Insider Monkey +7.74%
Sep-18-19 02:12PM  Are Insiders Selling Wave Life Sciences Ltd. (NASDAQ:WVE) Stock? Simply Wall St.
Sep-16-19 07:30AM  Wave Life Sciences Announces Fast Track Designation from U.S. FDA for Suvodirsen GlobeNewswire +14.45%
Sep-06-19 08:30AM  Wave Life Sciences to Host Analyst and Investor Research Day on October 7, 2019 GlobeNewswire -5.53%
Aug-26-19 04:05PM  Wave Life Sciences to Present at the Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-20-19 12:20PM  Sarepta's FDA rejection could have ripple effect in other Duchenne biotechs American City Business Journals
Aug-06-19 07:30AM  Wave Life Sciences Appoints Mark Baldry as Chief Commercial Officer GlobeNewswire
Jul-29-19 07:05PM  Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates Zacks -8.55%
04:05PM  Wave Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
Jul-17-19 03:23PM  Is Wave Life Sciences Ltd. (NASDAQ:WVE) Overpaying Its CEO? Simply Wall St.
Jul-01-19 09:35AM  Sarepta Up as Pfizer's DMD Gene Therapy Faces Safety Issues Zacks
Jun-27-19 08:00AM  Wave Life Sciences Announces Initiation of DYSTANCE 51, a Phase 2/3 Clinical Trial of Suvodirsen GlobeNewswire
08:00AM  Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer GlobeNewswire
Jun-12-19 08:00AM  Wave Life Sciences to Present at Parent Project Muscular Dystrophy 2019 Annual Conference GlobeNewswire
Jun-06-19 06:10PM  Vertex enters Duchenne field with $245M buy of Exonics American City Business Journals
May-10-19 08:45AM  Wave Life Sciences (WVE) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:42AM  Wave Life Sciences: 1Q Earnings Snapshot Associated Press
07:30AM  Wave Life Sciences Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
May-02-19 02:18PM  Is WAVE Life Sciences Ltd. (WVE) A Good Stock To Buy ? Insider Monkey
May-01-19 10:33AM  Wave Life Sciences (WVE) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-23-19 12:23PM  What Are Analysts Saying About Wave Life Sciences Ltd.'s (NASDAQ:WVE) Earnings Trajectory? Simply Wall St.
Apr-17-19 11:10AM  Wave Life Sciences Plunges After DMD Study Data Readout Zacks +6.29%
07:48AM  The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO Benzinga
Apr-16-19 05:17PM  Qualcomm and Progressive jump while Wave Life Sciences drops Associated Press -28.07%
12:14PM  Why Wave Life Sciences's Valuation Is Falling By 25% Benzinga
07:00AM  Wave Life Sciences Announces Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design GlobeNewswire
Apr-13-19 09:38AM  The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs Benzinga
Apr-12-19 08:00AM  Wave Life Sciences to Host Investor Conference Call to Discuss Suvodirsen DMD Clinical Data Being Presented at MDA Clinical and Scientific Conference GlobeNewswire
Apr-10-19 11:18AM  Wave Life Sciences Plunges on Clinical Trial Data Delay TheStreet.com -18.78%
07:00AM  Wave Life Sciences Provides Timing Update on PRECISION-HD Clinical Programs GlobeNewswire
Mar-28-19 10:20AM  Sarepta plans second Duchenne drug application this year American City Business Journals
Mar-25-19 08:00AM  Wave Life Sciences to Present Suvodirsen Phase 1 Safety and Tolerability Data and Phase 2/3 Clinical Trial Design at the Muscular Dystrophy Association Clinical and Scientific Conference GlobeNewswire
Mar-07-19 02:54PM  Should You Be Worried About Insider Transactions At Wave Life Sciences Ltd. (NASDAQ:WVE)? Simply Wall St.
Mar-06-19 08:00AM  Wave Life Sciences to Present at the Cowen 39th Annual Health Care Conference GlobeNewswire
Mar-01-19 07:30AM  Wave Life Sciences Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Business Update GlobeNewswire
Feb-22-19 07:45AM  Investor Expectations to Drive Momentum within Graphic Packaging Holding, Vulcan Materials, Omeros, Koppers, uniQure N.V, and WAVE Life Sciences Discovering Underlying Factors of Influence GlobeNewswire
Feb-12-19 01:17PM  Pioneer in Taking RNA Therpeutics Through the Clinic Joins Skyhawk Therapeutics as Chief Medical Officer PR Newswire
Jan-29-19 02:19PM  Why Wave Life Sciences Ltd.s (NASDAQ:WVE) CEO Pay Matters To You Simply Wall St. +5.29%
11:07AM  New life science internship program launches to help boost diversity American City Business Journals
Jan-24-19 12:21PM  Here's Why Wave Life Sciences Is Crashing Today Motley Fool -14.34%
08:48AM  Wave Life Sciences Prices $150 Million Public Offering of Ordinary Shares GlobeNewswire
Jan-23-19 04:23PM  Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares GlobeNewswire
Jan-15-19 06:07AM  FDA pilot program could help Wave avoid orphan-drug pitfalls American City Business Journals
Jan-04-19 11:38AM  Here's Why Sarepta Therapeutics Fell 15.7% in December Motley Fool +5.75%
Jan-03-19 08:00AM  Wave Life Sciences Duchenne Muscular Dystrophy Clinical Trial Selected for FDA Complex Innovative Trial Designs Pilot Program GlobeNewswire -5.07%
Dec-12-18 09:22AM  How Financially Strong Is Wave Life Sciences Ltd. (NASDAQ:WVE)? Simply Wall St.
Dec-06-18 07:30AM  Wave Life Sciences Announces Positive Phase 1 Results for WVE-210201 in Duchenne Muscular Dystrophy (DMD) GlobeNewswire
Nov-28-18 01:05PM  Leerink Starts Coverage Of Genetic Medicine Stocks: 'We See Commercial Execution As Increasingly Driving Returns' Benzinga +5.78%
Nov-09-18 08:55AM  Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates Zacks
07:49AM  Wave Life Sciences: 3Q Earnings Snapshot Associated Press
07:30AM  Wave Life Sciences Reports Third Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Nov-08-18 08:59AM  Wave Life Sciences to Present at the Jefferies 2018 London Healthcare Conference GlobeNewswire
Oct-24-18 07:35AM  Factors of Influence in 2018, Key Indicators and Opportunity within Inter Parfums, United Continental, Turning Point Brands, TPI Composites, Nelnet, and WAVE Life Sciences New Research Emphasizes Economic Growth GlobeNewswire -7.94%
Oct-09-18 02:38PM  Should You Be Holding Wave Life Sciences Ltd (NASDAQ:WVE) Right Now? Simply Wall St.
07:30AM  Wave Life Sciences to Develop Programs in Rare, Genetic Eye Diseases GlobeNewswire
Sep-20-18 08:00AM  Wave Life Sciences to Present New Data on Its DMD Exon 53 Skipping Program and Discovery Platform at Upcoming Meetings GlobeNewswire +7.22%
Aug-16-18 08:00AM  Wave Life Sciences Receives US Orphan Drug and Rare Pediatric Disease Designations for WVE-210201 GlobeNewswire
Aug-09-18 09:40AM  Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates Zacks
08:33AM  Wave Life Sciences: 2Q Earnings Snapshot Associated Press
08:00AM  Wave Life Sciences Reports Second Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
Jul-02-18 08:00AM  Wave Life Sciences Receives Positive Opinion for Orphan Drug Designation in the European Union for WVE-210201 GlobeNewswire
Jun-25-18 04:37PM  Wave Life Sciences to Present at Parent Project Muscular Dystrophy Annual Conference GlobeNewswire
Jun-07-18 08:20AM  Market Trends Toward New Normal in Gridsum Holding, Wave Life Sciences, KT, BlackBerry, Kosmos Energy, and Hovnanian Enterprises Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
May-31-18 05:11PM  Wave Life Sciences to Present at the Jefferies 2018 Healthcare Conference GlobeNewswire
May-11-18 12:02PM  Top Growth Stocks This Week Simply Wall St.
May-09-18 09:04AM  Wave Life Sciences: 1Q Earnings Snapshot Associated Press
08:00AM  Wave Life Sciences Reports First Quarter 2018 Financial Results and Provides Business Update GlobeNewswire
May-07-18 08:00AM  Wave Life Sciences Highlights Progress on Hepatic Collaboration with Pfizer GlobeNewswire
Apr-17-18 08:00AM  Wave Life Sciences to Present Data on ALS and FTD Programs and on Huntington's Disease at the 2018 American Academy of Neurology Annual Meeting GlobeNewswire
Apr-11-18 08:15AM  Investor Expectations to Drive Momentum within Xcerra, Grupo Aeroportuario del Centro Norte S.A.B. de C.V, WAVE Life Sciences, Hoegh LNG Partners LP, Mesoblast, and Intuitive Surgical Discovering Underlying Factors of Influence GlobeNewswire -5.08%
Apr-10-18 08:00AM  Wave Life Sciences and Deep Genomics Form Collaboration to Discover Novel Therapies for Genetic Neuromuscular Disorders GlobeNewswire
Apr-05-18 04:41PM  Wave Life Sciences to Present at Upcoming Investor Conferences GlobeNewswire
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on proprietary programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and commercial collaboration and multi-program option agreement with Wave Life Sciences Ltd. to develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Panzara Michael A.Chief Medical OfficerFeb 18Sale7.852,98123,40139,349Feb 20 06:26 PM
BOLNO PAULPresident and CEOFeb 18Sale7.8511,45189,890319,758Feb 20 06:23 PM
Francis ChrisSee RemarksFeb 18Sale7.852,70821,25831,160Feb 20 06:21 PM
Vargeese ChandraSenior VP, Drug DiscoveryFeb 18Sale7.853,18825,02637,057Feb 20 06:18 PM
Gaiero David GInterim CFOFeb 03Sale7.006514,5576,392Feb 05 06:16 PM
Vargeese ChandraSenior VP, Drug DiscoveryDec 03Option Exercise2.486,00014,88046,245Dec 05 06:08 PM
Vargeese ChandraSenior VP, Drug DiscoveryDec 03Sale35.006,000210,00040,245Dec 05 06:08 PM
Verdine Gregory L.DirectorNov 20Sale30.6330,039920,21330,000Nov 22 05:49 PM